Italia markets closed

ILMN Jan 2025 200.000 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
1,50000,0000 (0,00%)
In data: 03:43PM EDT. Mercato aperto.
Schermo intero
Chiusura precedente1,5000
Aperto1,5000
Denaro1,3000
Domanda1,6000
Prezzo d'esercizio200,00
Scadenza2025-01-17
Min-Max giorno1,5000 - 1,7500
Contratto - Min-MaxN/D
Volume17
Open Interest614
  • GlobeNewswire

    Myriad Genetics and Illumina Achieve Milestones in Strategic Partnership to Support Biopharma Clinical Trials

    Myriad can conduct prospective clinical trials using Illumina’s TruSight Oncology Comprehensive Investigational Use Only testSALT LAKE CITY, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced two key milestones in its strategic partnership with Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, to advance and support clinical research for gene-based, targeted thera